Scientific
PROGRAM
13 OCTOBER 2016 |
||
|
|
|
13:00-13:15 |
OPENING REMARKS |
Birol Guvenc - Giuseppe Saglio |
|
HIGHLIGHTS IN HEMATOLOGY - I - |
|
|
Moderators: Giuseppe Saglio, Hagop Kantarjian, Birol Guvenc |
|
13:15-13:45 |
Is Targeted Therapy On-Target? |
Robert Gale |
13:45-14:15 |
Chronic Myeloid Leukemia Beyond 2016 - Some Important Questions |
Hagop Kantarjian |
14:15-14:45 |
Is 400 mg OD the Correct Dosage of Imatinib? |
Rudiger Hehlmann |
14:45-15:15 |
Acute Myeloid Leukemia (AML) - Progress and Promises |
Hagop Kantarjian |
15:15-15:30 |
COFFEE BREAK |
|
|
HIGHLIGHTS IN HEMATOLOGY - II - |
|
|
Moderators: Ali Unal, Pervin Topcuoglu |
|
15:30-16:00 |
Iron Overload in MDS and in Stem Cell Transplantation - Is It An Issue? |
Eliezer Rachmilewitz |
16:00-16:30 |
Paroxysmal Nocturnal Hemogobinuria |
Hanan Hamed |
16:30-17:00 |
Chronic Lymphocytic Leukemia: Markers and Prognosis |
Kostas Stamatopoulos |
17:00-17:30 |
COFFEE BREAK |
|
|
|
|
|
ACUTE MYELOID LEUKEMIA SESSION |
|
|
Moderators: Mahmut Tobu, Ferit Avcu |
|
17:30-18:00 |
The Curable AMLs: APL And CBF AML |
Alan Burnett |
18:00-18:30 |
Molecular Biology Of AML: What And How Should We Monitor? |
Mehmet Yılmaz |
18:30-19:00 |
My Pesonal Vision of AML Treatment Today |
Farhad Ravandi |